SCHEMBL1994377

SCHEMBL1994377

NCC1CCN(c2nc(C3=C(c4c[nH]c5ccsc45)C(=O)NC3=O)c3ccccc3n2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCH P24723 20/20 0.59
PRKCQ Q04759 20/20 0.59
PRKCD Q05655 20/20 0.59
PRKCA P17252 19/20 0.59
PRKCB P05771 18/20 0.59
PRKCE Q02156 17/20 0.59
PRKD3 O94806 2/20 0.59
MAP4K4 O95819 2/20 0.59
PIM1 P11309 2/20 0.59
MARK3 P27448 2/20 0.59
LTK P29376 2/20 0.59
GRK5 P34947 2/20 0.59
KDR P35968 2/20 0.59
GSK3A P49840 2/20 0.59
RPS6KA3 P51812 2/20 0.59
JAK3 P52333 2/20 0.59
CDK5 Q00535 2/20 0.59
MAP2K1 Q02750 2/20 0.59
MST1R Q04912 2/20 0.59
PTK2 Q05397 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1995646 0.88 PRKCH (0.53) PRKCHPRKCQPRKCDPRKCAPRKCB
SCHEMBL1997337 0.87 PRKCH (0.54) PRKCHPRKCQPRKCDPRKCAPRKCB
SCHEMBL1994301 0.87 PRKCH (0.78) PRKCHPRKCQPRKCDPRKCAPRKCB
SCHEMBL1992057 0.87 PRKCH (0.76) PRKCHPRKCQPRKCDPRKCAPRKCB
SCHEMBL1995157 0.86 PRKCH (0.61) PRKCHPRKCQPRKCDPRKCAPRKCB
SCHEMBL1992528 0.86 PRKCH (0.59) PRKCHPRKCQPRKCDPRKCAPRKCB
SCHEMBL1997287 0.86 PRKCH (0.59) PRKCHPRKCQPRKCDPRKCAPRKCB
SCHEMBL1996844 0.86 PRKCH (0.63) PRKCHPRKCQPRKCDPRKCAPRKCB
SCHEMBL12604693 0.86 PRKCH (0.65) PRKCHPRKCQPRKCDPRKCAPRKCB
SCHEMBL1991410 0.86 PRKCH (0.53) PRKCHPRKCQPRKCDPRKCAPRKCB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO PRKCH 3138/4885PRKCQ 3598/4885PRKCD 2857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.